Biotechnology Atai Life Sciences Q4 And Full-Year 2023 Results: Steep Cash Drain Yet 2026 Target Remains, Update On Psychedelic Pipeline – Compass Pathways (NASDAQ:CMPS), ATAI Life Sciences (NASDAQ:ATAI) Read more
Biotechnology Why Is Cancer Focused Xilio Therapeutics Stock Trading Higher On Thursday? – Xilio Therapeutics (NASDAQ:XLO), Gilead Sciences (NASDAQ:GILD) Read more
Biotechnology Intranasal 5-MeO-DMT Clinical Trial Offers Hope For Treatment-Resistant Depression – ATAI Life Sciences (NASDAQ:ATAI) Read more
Biotechnology Psyched: LSD, Psilocybin As Breakthrough Therapies, $14M Fed Grant For Ibogaine, Indiana’s Research And More – ATAI Life Sciences (NASDAQ:ATAI), Clearmind Medicine (NASDAQ:CMND) Read more
Biotechnology Psychedelics Headlines: Substitution Survey, Frank Herbert’s Magic Mushrooms, Celestial Plans And News Review – ATAI Life Sciences (NASDAQ:ATAI), BetterLife Pharma (OTC:BETRF) Read more
Biotechnology Gilead’s Aggressive Push Beyond HIV Treatments – Plans To Increase Cancer-Focused CAR-T Treatment Production – Gilead Sciences (NASDAQ:GILD) Read more
Opinion Thinking about buying stock in Lexicon Pharmaceuticals, Cassava Sciences, Clearside Biomedical, Lantern Pharma, or ATAI Life Sciences? – Clearside Biomedical (NASDAQ:CLSD), ATAI Life Sciences (NASDAQ:ATAI) Read more
Cannabis Cannabis Adviser Golden Eagle Advocates For Life Sciences, Promotes New Terms For THC Read more
Stockmarkets 180 Life Sciences Corp board member Sir Marc Feldmann resigns By biedexmarkets.com Read more
Stockmarkets Oppenheimer remain bullish on Gilead Sciences , HIV agents in 24/25 could provide conviction to investors By biedexmarkets.com Read more